Cartalax

cartilage, joint, and connective tissue health Cartalax is a short chain bioregulatory peptide tripeptide Ala Glu Asp developed in Russia, designed to support cartilage, joint, and connective tissue health. It works by interacting with DNA to stimulate cartilage cell chondrocyte regeneration, improve collagen metabolism, and reduce joint aging, often used for conditions like osteochondrosis and arthritis. s a Khavinson peptide, it is believed to act at the genetic level to regulate cellular, specifically targeting cartilage tissues and slowing down age related degradation. Benefits: It is used to promote the regeneration of cartilage, strengthen ligaments, and improve overall joint flexibility.